United States · 
Who invested in Amplyx Pharmaceuticals?
Amplyx Pharmaceuticals's investors include New Enterprise Associates, RiverVest and BioMed Ventures.
2016
$1.5MDebt$41MSeries B
United States · Series B startup
Who invested in Amplyx Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$42Mraised across 2 rounds since 2015, from 2 sources
$1.5MDebt$41MSeries B
- Latest round
- Series B, $41MNov 2015
- Step-upi
- 27×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Debt, $1.5M Aug 2015
- Biggest round
- $41M Series B · Nov 2015
- Between rounds
- 3 months from the last two
The rounds
- Nov 2015Series B$41M3 new
From a historical funding recordSEC filing: $20M sold, first sale Oct 2015
- Aug 2015Debt$1.5M
No investor was named in the report.
From a historical funding recordSEC filing: $1.5M sold, first sale Aug 2015
Founders and team
From the SEC filings it signed: 3 on the team.
- Alan FuhrmanExecutive Officeri
- Ciara KennedyExecutive Officer, Directori
- Mike HodgesExecutive Officeri
On the board, as filediAnand MehraEdward MathersElaine HeronJohan KordelMichael GreyNiall ODonnellPaul Grint
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Amplyx Pharmaceuticals
How much has Amplyx Pharmaceuticals raised?
Amplyx Pharmaceuticals has raised $42M across 2 rounds since 2015.
When did Amplyx Pharmaceuticals last raise?
Amplyx Pharmaceuticals's most recent round was a Series B of $41M in Nov 2015.
What was Amplyx Pharmaceuticals's biggest round?
Its most recent round, $41M in Nov 2015, is also its largest on record.
Who backed Amplyx Pharmaceuticals first?
Amplyx Pharmaceuticals's first round on record, in Nov 2015, was backed by New Enterprise Associates, RiverVest and BioMed Ventures.
What stage is Amplyx Pharmaceuticals at?
Amplyx Pharmaceuticals's latest named round is a Series B, in Nov 2015.
Where is Amplyx Pharmaceuticals based?
Amplyx Pharmaceuticals is based in the United States.
Companies like Amplyx Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.